Nathan Wolfe is founder of Global Viral (previously GVFI) and Metabiota, a company that specializes in microbiological research, products and services, and the Ex-Chairman of Global Viral, a non-profit that promotes understanding, exploration and stewardship of the microbial world. Dr. Wolfe received his doctorate in Immunology & Infectious Diseases from Harvard in 1998.

He has received numerous awards including a Fulbright fellowship and the NIH Director’s Pioneer Award and was named a National Geographic Emerging Explorer in 2009 and a World Economic Forum Young Global Leader in 2010. Dr. Wolfe has over eight years of experience living and conducting biomedical research in Southeast Asia (Malaysia) and sub-Saharan Africa (Cameroon and Uganda), and he currently coordinates activities of over 50 scientists and staff in countries around the world.

He has received support totaling over $60m in grants and contracts from Google, the National Institutes of Health, the National Science Foundation, the Bill & Melinda Gates Foundation, the US Department of Defense among others. He has over 80 scientific publications, and his critically acclaimed book, The Viral Storm, has been published in six languages and was shortlisted in 2012 for the Royal Society’s Winton Prize.¹⁾

D.Sc. (Immunology & Infectious Disease), Harvard University M.A. (Biological Anthropology), Harvard University ​ Research focus- Biodiversity, ecology and evolution of microbes, Infectious diseases monitoring ​ Other appointments and previous roles- Lorry I. Lokey Business Wire Consulting Professor in Human Biology, Stanford University (2008-2017) Chairman of the Board, Metabiota (2016- ) Chief Executive Officer, Metabiota (2008-16) Professor, University of California, Los Angeles (2006-08) Assistant Professor, Johns Hopkins University (2003-06)²⁾ ​

In 2018, News Front, a website based in Crimea, published an article ‘CyberBerkut; USA taking control over biological research in Ukraine’. The article states;

“The USA is gaining total control over biological research facilities, researchers and stocks of deadly viruses in Ukraine. This will allow the USA to control epidemiological situation in the region, get access to every development in the sphere and manipulate population size while increasing American pharmaceutical corporations’ profit.

“The Pentagon has got access to Ukrainian biological research facilities under the plausible pretext of preventing the proliferation of biological weapons. The biological projects are sponsored and supervised by the U.S. Defence Threat Reduction Agency (DTRA), which is operating through its office in the U.S. Embassy in Kyiv, headed by Joanna Wintrol.

“The American engineering firm Black & Veatch is covering construction and maintenance of biological facilities and conducting biological researches under special projects. By a lucky chance, Metabiota, a subcontractor, is sharing the building with Black & Veatch in Kyiv.”

From 2008 to 2017, Black & Veatch and DTRA signed contracts, estimated at $215.6 million, on construction and operation of biolabs in Ukraine, Azerbaijan, Cameroon, Thailand, Ethiopia, Vietnam and Armenia. Under the program in Georgia and Ukraine, the company Metabiota, Black & Veatch subcontractor, signed a $18.4 million federal contract.

The News Front article goes on to describe visits in March, May and June 2018 by a US delegation to Odessa, Kharkiv and Lviv respectively. The US delegation comprised US Embassy delegates and representatives of Black & Veatch subcontractors. The purpose was to implement a “system of pathogens control management” during which Black & Veatch gained access to “especially dangerous pathogens” at the disposal of the Ukrainian Ministry of Defence.³⁾

Dilyana Gaytandzhieva, a Bulgarian journalist, identified US biotech company Metabiota Inc. in an extremely detailed 2019 article as the main player in the Ukrainian labs.⁴⁾ It’s a company that tracks the trajectory of outbreaks and sells pandemic insurance, but also seems to have its hand in the actual labs that, as we painfully learned the past two years, might be the source of some of these outbreaks.

Biowarfare scientists, using diplomatic cover, test man-made viruses at Pentagon biolaboratories in 25 countries across the world, Dilyana Gaytandzhieva wrote in 2018. These US biolaboratories are funded by the Defence Threat Reduction Agency (“DTRA”) under a $ 2.1 billion military program – Cooperative Biological Engagement Program (“CBEP”) – and are located in former Soviet Union countries, such as Georgia and Ukraine, the Middle East, South East Asia and Africa.

DTRA has outsourced much of the work under the military program to private companies, which are not accountable to Congress, and which can operate more freely and move around the rule of law. As Gaytandzhieva identified, one such company is Metabiota.

Metabiota works with partners around the world to push scientific boundaries and develop new knowledge. “We have deep and sustained partnerships with governments, health agencies, academic institutions and private enterprise,” their website states.⁵⁾

The US Company Metabiota Inc. has been awarded $18.4 million federal contracts under the Pentagon’s DTRA program in Georgia and Ukraine for scientific and technical consulting services. Metabiota services include global field-based biological threat research, pathogen discovery, outbreak response and clinical trials. Metabiota Inc. had been contracted by the Pentagon to perform work for DTRA before and during the Ebola crisis in West Africa and was awarded $3.1 million (2012-2015) for work in Sierra Leone – one of the countries at the epicenter of the Ebola outbreak.⁶⁾

The exact amount of funds that Carroll diverted from USAID’s pandemic program to set up the GVP remains unclear. In their release of documents, US Right to Know published a spreadsheet showing that $270,969 in USAID PREDICT funds were diverted to the GVP. However, other internal emails show USAID PREDICT contractors discussing GVP funds that were earmarked for Columbia University as well as $341,000 designated for a GVP benefit cost analysis study.

“I plan on obligating those funds to Metabiota as soon as the balance of our [year 5] obligation is received by USAID, but please let me know if this is unacceptable, and I’ll see what can possibly be done (creative accounting required).”

To this day, the financial supporters of the Global Virome Project are uknown. In early 2019, Edward “Eddy” Rubin of Metabiota emailed fellow GVP board member Jonna Mazet of UC Davis, as well as Dennis Carroll at USAID, to complain that the GVP was not finding backers.

“USAID while supportive may not going forward be our champion,” Rubin with Metabiota wrote. “Maybe we need to keep on searching for a champion as the project clearly has not found one. Maybe China.”⁷⁾

Rosemont Seneca Technology Partners (RSTP) – a subsidiary of the Hunter Biden and Christopher Heinz -founded Rosemont Capital – counted both Biden and Heinz as managing directors. Heinz is the stepson of former U.S. Secretary of State and current Climate czar John Kerry.

Amongst the companies listed on archived versions of the RSTP’s portfolio is Metabiota – an ostensibly San Francisco-based company that purports to detect, track, and analyze emerging infectious diseases.

Financial reports reveal that RSTP led the company’s first round of funding in 2015, which amounted to $30 million. Former managing director and co-founder of RSTP Neil Callahan – a name that also appears many times on Hunter Biden’s hard drive – sits on Metabiota’s Board of Advisors alongside former Clinton official Rob Walker who discussed, in another unearthed Hunter Biden hard drive e-mail, reaching out to the Obama Department of Defense with regard to Metabiota.

In July 2021, The National Pulse exclusively revealed the connection between Metabiota, Hunter Biden, and the pandemic-linked EcoHealth Alliance which worked closely with Anthony Fauci’s National Institute for Allergy and Infectious Disease (NIAID) and the notorious Wuhan laboratory.

Government contracts also corroborate the working relationship between Metabiota, Ukrainian laboratories, and the U.S. Defense Department, with the firm receiving an $18.4 million grant from the U.S. agency in 2014. A total of $307,091, allocated to Metabiota on September 25th, was itemized for “Ukraine research projects.” Several scientific papers – including those isolating strains of deadly pathogens like “virulent African Swine Fever Virus” – appear to have been published following the grant.

A 2019 paper titled “Complete Genome Sequence of a Virulent African Swine Fever Virus from a Domestic Pig in Ukraine” was authored by researchers from Metabiota and three Ukraine-based institutes.⁸⁾

Pentagon-Ukraine Bio Labs: The Hunter Biden Connection Match 23, 2022 by Freddie Ponton -21st Century Wire

This firm is a key fulcrum in the new global pandemic industrial complex.

Global Viral started out as a non-profit in 2008 with seed funding from Google and the Skoll Foundation, and 22 other investors according to a Marlin & Associates Report, also revealing that the initial round of investment Series A funding was led by none other than Rosemont Seneca Partners.

Rosemont Seneca Partners is an investment fund firm. The fund was named after the Rosemont Farm, the Heinz family estate located near Pittsburgh. The firm was founded in 2009 by Christopher Heinz, stepson of former U.S. Secretary of State John Kerry, Devon Archer, a businessman and a former Abercrombie & Fitch model who was Heinz’s college classmate, and Hunter Biden, son of current US President Joe Biden.⁹⁾